381 related articles for article (PubMed ID: 33499229)
1. Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes.
Vascellari S; Melis M; Palmas V; Pisanu S; Serra A; Perra D; Santoru ML; Oppo V; Cusano R; Uva P; Atzori L; Morelli M; Cossu G; Manzin A
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499229
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota in patients with Parkinson's disease in southern China.
Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
[TBL] [Abstract][Full Text] [Related]
5. Alterations of gut microbiota and metabolome with Parkinson's disease.
Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L
Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073
[TBL] [Abstract][Full Text] [Related]
6. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
[TBL] [Abstract][Full Text] [Related]
7. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson's disease with Buyang Huanwu decoction.
Hu J; Li P; Zhao H; Ji P; Yang Y; Ma J; Zhao X
J Ethnopharmacol; 2024 Jan; 318(Pt A):116893. PubMed ID: 37423520
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa-carbidopa intrajejunal gel.
Melis M; Vascellari S; Santoru ML; Oppo V; Fabbri M; Sarchioto M; Murgia D; Zibetti M; Lopiano L; Serra A; Palmas V; Pisanu S; Perra D; Madau V; Cusano R; Uva P; Mereu A; Contu P; Morelli M; Atzori L; Melis M; Manzin A; Cossu G
Eur J Neurol; 2021 Apr; 28(4):1198-1209. PubMed ID: 33185912
[TBL] [Abstract][Full Text] [Related]
10. Altered gut microbiota in Parkinson's disease patients with motor complications.
Takahashi K; Nishiwaki H; Ito M; Iwaoka K; Takahashi K; Suzuki Y; Taguchi K; Yamahara K; Tsuboi Y; Kashihara K; Hirayama M; Ohno K; Maeda T
Parkinsonism Relat Disord; 2022 Feb; 95():11-17. PubMed ID: 34954497
[TBL] [Abstract][Full Text] [Related]
11. Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease.
van Kessel SP; El Aidy S
J Parkinsons Dis; 2019; 9(s2):S359-S370. PubMed ID: 31609701
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota are related to Parkinson's disease and clinical phenotype.
Scheperjans F; Aho V; Pereira PA; Koskinen K; Paulin L; Pekkonen E; Haapaniemi E; Kaakkola S; Eerola-Rautio J; Pohja M; Kinnunen E; Murros K; Auvinen P
Mov Disord; 2015 Mar; 30(3):350-8. PubMed ID: 25476529
[TBL] [Abstract][Full Text] [Related]
13. IgA-Biome Profiles Correlate with Clinical Parkinson's Disease Subtypes.
Brown EL; Essigmann HT; Hoffman KL; Alexander AS; Newmark M; Jiang ZD; Suescun J; Schiess MC; Hanis CL; DuPont HL
J Parkinsons Dis; 2023; 13(4):501-513. PubMed ID: 37212075
[TBL] [Abstract][Full Text] [Related]
14. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
15. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
Heravi FS; Naseri K; Hu H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
[TBL] [Abstract][Full Text] [Related]
17. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of TAS2R38 bitter taste receptor associate with distinct gut microbiota traits in Parkinson's disease: A pilot study.
Vascellari S; Melis M; Cossu G; Melis M; Serra A; Palmas V; Perra D; Oppo V; Fiorini M; Cusano R; Morelli M; Manzin A; Barbarossa IT
Int J Biol Macromol; 2020 Dec; 165(Pt A):665-674. PubMed ID: 32946938
[TBL] [Abstract][Full Text] [Related]
19. The faecal metabolome and mycobiome in Parkinson's disease.
De Pablo-Fernandez E; Gebeyehu GG; Flain L; Slater R; Frau A; Ijaz UZ; Warner T; Probert C
Parkinsonism Relat Disord; 2022 Feb; 95():65-69. PubMed ID: 35045378
[TBL] [Abstract][Full Text] [Related]
20. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
